Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GENFIT
  6. News
  7. Summary
    GNFT   FR0004163111

GENFIT

(GNFT)
  Report
Real-time Euronext Paris  -  11:35 2022-10-06 am EDT
3.866 EUR   +0.26%
09/30European ADRs Move Higher in Friday Trading
MT
09/30Genfit Finalizes $41 Million Purchase of Liver Disease-focused Versantis
MT
09/29GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Lower in Tuesday Trading

06/14/2022 | 11:06am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -0.45% 1.095 Delayed Quote.-70.67%
BP PLC 0.03% 460.35 Delayed Quote.39.24%
DBV TECHNOLOGIES 0.24% 3.41 Real-time Quote.11.21%
EQUINOR ASA 1.06% 375.05 Real-time Quote.57.31%
ERYTECH PHARMA S.A. 0.78% 0.642 Real-time Quote.-69.95%
FORWARD PHARMA A/S -2.70% 2.88 Delayed Quote.-50.42%
GENFIT 0.26% 3.866 Real-time Quote.-10.66%
HSBC HOLDINGS PLC -0.23% 471.3 Delayed Quote.5.29%
LLOYDS BANKING GROUP PLC -0.76% 42.53 Delayed Quote.-10.35%
LONDON BRENT OIL 0.34% 94 Delayed Quote.17.76%
MEREO BIOPHARMA GROUP PLC -0.54% 0.96 Delayed Quote.-39.68%
NOKIA OYJ -0.31% 4.6005 Delayed Quote.-17.20%
NUCANA PLC 4.83% 1.05 Delayed Quote.-57.92%
TRIVAGO N.V. -2.21% 1.1937 Delayed Quote.-44.50%
VOXELJET AG -2.10% 3.27 Delayed Quote.-43.39%
WPP PLC 0.96% 778.4 Delayed Quote.-31.13%
WTI 0.09% 88.107 Delayed Quote.16.82%
All news about GENFIT
09/30European ADRs Move Higher in Friday Trading
MT
09/30Genfit Finalizes $41 Million Purchase of Liver Disease-focused Versantis
MT
09/29GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Ac..
GL
09/29GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Ac..
AQ
09/29GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
AQ
09/29Genfit S.A. acquired Versantis AG for approximately CHF 110 million.
CI
09/28GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
GL
09/28GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
GL
09/28Genfit S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
09/19Transcript : Genfit S.A., Versantis AG - M&A Call
CI
More news
Analyst Recommendations on GENFIT
More recommendations
Financials
Sales 2022 17,8 M 17,6 M 17,6 M
Net income 2022 -46,9 M -46,3 M -46,3 M
Net cash 2022 88,8 M 87,5 M 87,5 M
P/E ratio 2022 -4,02x
Yield 2022 -
Capitalization 191 M 188 M 189 M
EV / Sales 2022 5,75x
EV / Sales 2023 3,29x
Nbr of Employees 134
Free-Float 86,8%
Chart GENFIT
Duration : Period :
GENFIT Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENFIT
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 3,86 €
Average target price 9,90 €
Spread / Average Target 157%
EPS Revisions
Managers and Directors
Pascal Prigent Chief Executive Officer
Thomas Baetz Chief Financial Officer
Jean-François Mouney Chairman
Dean W. Hum Chief Scientific Officer
Carol L. Addy Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GENFIT-10.66%189
MODERNA, INC.-50.54%49 142
LONZA GROUP AG-33.72%38 001
IQVIA HOLDINGS INC.-31.78%35 901
SEAGEN INC.-11.47%25 244
ALNYLAM PHARMACEUTICALS, INC.18.67%24 128